The Company is subject to the provisions of the City Code on Takeovers and Mergers.
Verici Dx has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.
Number of AIM securities in issue: 242,541,467 shares are issued, called up and fully paid. The Company holds no shares in treasury.
This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.
This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.
As of 31 March 2025, the following interests in 3% or more of the issued Ordinary Share capital, after taking account of the issue of new shares post year end pursuant to the funding, had been notified to the Company:
| Significant shareholders | No. of ordinary shares | % held |
| Harwood Capital | 36,390.843 | 15.00% |
| Octopus Investments Limited | 21,479,825 | 8.86% |
| Unicorn Asset Management Limited | 20,350,771 | 8.39% |
| Icahn School of Medicine at Mount Sinai | 19,501,330 | 8.04% |
| Hargreaves Lansdown Asset Management | 17,358,923 | 7.16% |
| Amati Global Investors Limited | 12,161,111 | 5.01% |
| Interactive Investor | 11,817,266 | 4.87% |
| Rathbone Investment Management | 9,252,149 | 3.81% |
| Renalytix plc | 8,581,682 | 3.54% |
| Canaccord Genuity Wealth Management | 7,618,638 | 3.14% |
*Christopher Mills is partner and Chief Investment Officer of Harwood Capital LLP. Harwood Capital LLP is Investment Manager to North Atlantic Smaller Companies Investment Trust plc and investment adviser to Oryx International Growth Fund Limited. Christopher’s shareholding is made up of 23,000,000 ordinary shares held by North Atlantic Smaller Companies Investment Trust PLC, 18,000,000 ordinary shares are held by Oryx International Growth Fund Limited and 5,390,843 ordinary shares are held by Harwood Capital LLP.
| Director | Number | Ordinary Shares % |
| Julian Baines MBE | 1,629,490 | 0.7% |
| James McCullough | 2,870,110 | 1.2% |
| Sir Ian Carruthers | 100,000 | 0.04% |
Percentage of securities not in public hands: 31 March 2025 the percentage of AIM securities not in the public hands was 28.68%. The securities not in public hands include all substantial shareholders and the directors and senior management who are classed as persons discharging managerial responsibilities.
There are no restrictions on the transfer of the Company’s ordinary shares.
Last updated: 31 March 2025
Singer Capital Markets
1 Bartholomew Lane
London
EC2N 2AX
Shoosmiths LLP
No 1 Bow Churchyard
London
EC4M 9DQ
